iteriabiopharma.comCrawled Oct 24, 2026
Iteria Biopharma develops new cancer therapies based on MAO-A inhibition as part of a Public-Private Partnership project funded by the Ministerio de Ciencia, Innovación y Universidades.
Iteria Biopharma, founded in Galicia by GalChimia, Julio Castro, and Ramon Bosser, develops drugs for cancer treatment with funding from Inveready and Xesgalicia.
Iteria Biopharma, based in Touro (A Coruña, Spain), develops prostate cancer treatments and joins Galicia’s biotechnology ecosystem.
Iteria Biopharma, a Galician biotech, focuses on precision drugs for cancer treatment, led by GalChimia, Julio Castro, and Ramon Bosser.
Laboratory equipment refers to the various tools and equipment.
The page outlines a PhD molecular biologist with 10 years in academia who later became CEO of Advancell and worked in 15+ companies, raising over 40M€ for clinical-stage projects.
Board of directors Co-Founder Carme Pampín Co-Founder Julio Castro Co-Founder & CEO Ramon Bosser General Partner Sara Secall Board Member Yolanda Falcón Our team Co-Founder & CEO Ramon Bosser Head of Chemistry and Research Raúl Fernández Chief Scientific Officer Judit Anido Project Manager Jesús Álvarez Clinical Project Manager Cristina López Business Development Director Luis Ruiz-Ávila
Sara joined Inveready in 2013 and oversees the biotech portfolio, leading transactions such as AVX Pharma and Edesa Biotech.
IteriaBiopharma is a Spanish biotech founded in 2024 by entrepreneurs with experience in drug discovery, including prior work at Origo Biopharma.
The page provides contact information for Iteria Biopharma, including its address in Touro, A Coruña, and email address.
Iteria Biopharma SL complies with Law 34/2002 on Information Society and Electronic Commerce Services for its website.